It would be of great interest to determine whether lung cancer cells respond to CXCL13 by activating signaling pathways related to proliferation and survival, as this may reveal important direct effects of the chemokine resulting from paracrine or autocrine mechanisms. This evidence concerns the gene CXCL13 and lung carcinoma.